去甲肾上腺素在可电击心律心脏骤停中的作用:范围综述
该范围综述检索了PreMedline、Medline、Embase和Cochrane数据库,筛选3308篇文献后最终纳入18篇(5项人体研究、13项动物研究)。去甲肾上腺素似乎能优化大循环与心肌血流动力学、增加区域脑血流,并可能改善生存。作者认为,尽管证据有限,去甲肾上腺素在多项血流动力学参数和可能的生存方面似乎优于肾上腺素。
要点
- 在可电击心律心脏骤停期间给予去甲肾上腺素,动物研究显示可优化大循环与心肌血流动力学。
- 去甲肾上腺素可能增加区域脑血流,并可能改善生存,人体研究中也提示类似信号。
- 证据主要来自动物研究(13项),人体研究仅5项,总体证据有限。
- 去甲肾上腺素因对α和β肾上腺素能受体亲和力差异,可能作为肾上腺素的替代选择。
适用人群与场景
- 可电击心律心脏骤停患者,涉及院外心脏骤停场景。
研究设计与关键结果
- 研究类型为范围综述,检索PreMedline、Medline、Embase和Cochrane数据库,去重后筛选3308篇文献,全文分析46篇,最终纳入18篇(5项人体研究、13项动物研究)。
- 去甲肾上腺素似乎能优化大循环与心肌血流动力学,增加区域脑血流,并可能改善生存。
- 动物研究显示去甲肾上腺素在可电击心律心脏骤停期间给药具有多项有益效应,人体研究中也提示类似信号。
证据类型、等级与局限
- 证据类型为范围综述,纳入随机对照试验、实验研究和观察性研究(包括病例报告),排除指南、综述和评论。
- 作者认为尽管证据有限,去甲肾上腺素在多项血流动力学参数和可能的生存方面似乎优于肾上腺素。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为去甲肾上腺素在可电击心律心脏骤停期间给药可能提供多项血流动力学参数和可能的生存优势,但证据主要来自动物研究,人体研究仅提示类似信号。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Out-of-hospital cardiac arrest is considered a major public health issue with an incidence of 67-170 per 100.000 inhabitants in Europe. Sufficient coronary perfusion pressure is a requisite for successful defibrillation and return of spontaneous circulation (ROSC). Although epinephrine (E) was found to increase ROSC and hospital survival when compared to placebo, its role in shockable arrest is under debate due to the absence of favorable neurological outcome.
OBJECTIVE: Norepinephrine (NE) increases coronary perfusion pressure and may be an alternative for epinephrine because of differences in affinity in alpha- and beta- adrenergic receptors.
METHODS: An extensive literature search was conducted in PreMedline, Medline, Embase and Cochrane electronic databases. All original studies (randomized controlled trials, experimental and observational studies, including case-reports) were included; guidelines, (editorial) reviews and commentaries were excluded, no date constraints were applied. Articles were included in the literature review if they described intra-arrest administration of norepinephrine and contained at least an abstract in English, French, or German.
RESULTS: A total of 3308 articles were screened after deduplication. Following initial title/ abstract screening, full-texts analysis was performed in n = 46 studies. A total of 18 articles were included, consisting of 5 human and 13 animal studies. Norepinephrine appears to optimize macrocirculatory-and myocardial hemodynamics, increased regional cerebral blood flow and might improve survival.
CONCLUSION: Norepinephrine has shown several beneficial effects when administered during shockable cardiac arrest in animal studies, with similar signals suggested in human studies. Despite the limited evidence, norepinephrine appears to offer potential advantages over epinephrine in terms of multiple haemodynamic parameters and possible survival.
参考来源
- Bouman SJM, Baldussu E, Franssen GHLM, et al. The effects of norepinephrine in shockable cardiac arrest, a scoping review. Scand J Trauma Resusc Emerg Med. 2025. PMID: 41039564. doi:10.1186/s13049-025-01480-6
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。